testosterone and dehydroepiandrosterone were elevated. Androgens remained unchanged after adrenocorticotropic hormone, and dexamethasone administrations. Ultrasound examination and magnetic resonance imaging indicated an extra-adrenal mass adjacent to the left adrenal gland, which was removed by endoscopic surgery. However, plasma androgens remained elevated and 131 I-iodomethyl-norcholesterol scintigraphy revealed tracer enhancement in the right adrenal gland, which was consecutively removed. Virilization regressed after extirpation of the adenomas and height
Introduction
Adrenocortical tumors (ACT) are rare in children. The worldwide annual incidence ranges from 0.3 to 0.38 per million children below the age of 15 years, with 65% occurrence in children younger than 5 years [1, 2] . In young children, the incidence of ACT seems to be higher for young girls with a female/male ratio of 2: 1, whereas in adolescents, the female/male ratio is 1: 1 [3] [4] [5] . In contrast to adults, the most frequent presentation in children with ACT is virilization, followed by hypercortisolism and hyperaldosteronism [6, 7] . The diagnosis is supported when serum levels of dehydroepiandrosterone (DHEA), DHEA sulfate, androstenedione, and testosterone are elevated. The localization of the rather small tumors may be difficult, especially by abdominal ultrasound. These extremely rare tumors are exceptionally located bilateral or ectopic, but to our knowledge no concomitant ectopic bilateral adrenal adenomas causing virilization in children are described in the literature [8, 9] . To verify that the ectopic lesion is from adrenal origin detecting the expression of the melanocortin 2 (MC2) receptor could be useful [10] . Here, we report a young girl with concomitant ectopic and intra-adrenal adenomas of the adrenal cortex diagnosed by 131 I-iodomethylnorcholesterol scintigraphy.
Case Report
At the age of 2 years and 4 months the girl was referred for evaluating premature pubarche. Her parents had recognized pubic hair 5 months ago. She presented with pubertal stages according to Tanner breast 1, pubic hair 3, and distinct clitoral hypertrophy, no acne, no axillary hair, and no striae [11] . The girl was tall (102 cm; SDS +2.94) and her height velocity was increased (10.7 cm/years; SDS 1.98) ( fig. 1 ). Biochemical assessment revealed normal serum electrolytes. Basal morning plasma concentrations of 17-hydroxyprogesterone 3.12 nmol/l (reference range 0.09-2.73), androstenedione 4.6 nmol/l (reference range 0.17-1.75), testosterone 7.08 nmol/l (reference range <0.69), DHEA 9.4 nmol/l (reference range 0.69-4.51), and DHEA sulfate 0.34 μmol/l (reference range <0.052) were notably elevated. The urinary steroid metabolome revealed a 2.5-fold elevated excretion rates of androgen metabolites, such as androsterone, etiocholanolone, 16-alpha-hydroxy-DHEA, 5-androstene-3β,17β-diol, 3β,16α,17β-androstenetriol, 11-OH-androsterone, and testosterone. Glucocorticosteroid excretion in 24-hour urine, circadian adrenocorticotropic hormone (ACTH), and cortisol were not elevated. The bone age (Greulich and Pyle) was accelerated to 4 2/12 years [12] . Initially, we presumed that the underlying disease was 21-hydroxylase-deficiency or other forms of virilizing congenital adrenal hyperplasia, but finally this hypothesis was excluded by ACTH test, molecular genetic analysis, and urinary steroid metabolomics analysis.
As part of the clinical work-up, abdominal ultrasound was performed, which revealed a slightly thickened right adrenal gland, while the left adrenal gland was normal. In contrast, MRI revealed an ectopic tumor in the area of the left renal hilus with a diameter of 13 mm. Surgical excision of this ectopic lesion disclosed a beige tumor measuring 1.8 × 1 × 0.8 cm. However, de- 20  19  18  17  16  15  14  13  12  11  10  9  8  7  6  5  4  3  2  1  0   20  19  18  17  16  15  14  13  12  11  10  9  8  7  6  5  4  3 
Methods
Serum steroid hormones were determined by radioimmunoassays using tritiated steroids (Amersham Biosciences, Freiburg, Germany) and specific antibodies, raised and characterized in the steroid laboratory, as described elsewhere [13] . The urinary steroid metabolome was assessed by gas chromatography-mass spectrometry [14] .
RNA was extracted from the ectopic tumor in the area of the left adrenal gland (QIAGEN, Hilden, Germany). MC2 receptor and LH receptor mRNA expression were investigated by quantitative PCR according to Zwermann et al. [10] .
The patient's parents were informed about all the diagnostic procedures and gave their written consent for the necessary surgery, tumor removal, and analysis of tumor tissue.
Results
Histological examination of the ectopic lesion close to the left renal hilus revealed an oxyphilic epithelial tumor with a Ki67 proliferation index ranging from 2 to 5%. Staining was positive for synaptophysin, melan-A, inhibin, and CD56, weak staining for calretinin. β-human chorionic gonadotropin hormone, alpha-1-fetoprotein, placental alkaline phosphatase, protein S100, and chromogranin A were not detectable. In the ectopic tumor MC2R expression was threefold higher in comparison to normal adrenal glands while only low expression of the LH receptor was detected in comparison to normal adrenals ( fig. 2 ) . The intra-adrenal tumor of the right adrenal gland contained oxyphilic epithelial cells with a Ki67 proliferation index of 2-5% and no invasion of the capsula or vessels were detected. Further immunohistochemical investigation demonstrated positive staining for synaptophysin, vimentin, melan-A, inhibin and CD56, while panzytokeratin (KL-1), calretinin, CD 31, protein S100 and chromogranin A were not detectable.
Discussion
We herein describe a young girl who presented with precocious pseudopuberty caused by concomitant ectopic and intra-adrenal adenomas of the adrenal cortex. Initially, we supposed that adrenal congenital hyperplasia was the underlying disease. Finally, this clinical picture was excluded and we presumed an adrenal tumor is causing virilization. Clinical signs of virilizing adrenal tumors in children include precocious pubic hair, hypertrophy of the penis or clitoris, acne, gynecomastia, increased height velocity, and accelerated bone age. Diagnosis is supported by measuring plasma DHEA, DHEA sulfate, androstenedione, testosterone, 17OHP, and urinary steroids [15] [16] [17] [18] . In addition, these hormones are also helpful as follow-up markers for detection of recurrence of the disease until puberty. The preoperative mandatory precise location of the tumors in the case of small lesions can present as a particular clinical challenge. In the presented case initial abdominal ultrasound investigations failed to detect the tumor. Furthermore, during the initial abdominal MRI only the ectopic tumor in the left renal hilus was visualized, while the procedure failed to detect the small nodule in the right adrenal gland. But after extirpation of the ectopic tumor of the left adrenal gland hyperandrogenism persisted. Because using con- ventional imaging techniques localization of the second tumor was not successful, 131 I-iodomethylnorcholesterol scintigraphy was performed. This method has been reported to provide a higher sensitivity in localizing steroid-secreting lesions in comparison to MRI and correlates well with steroid biosynthesis [19] . However, the tracer is associated with a substantial radiation dosage and experiences in children are limited. In most European countries the production of the tracer has been terminated [20] . Recently, 123 I-iodometomidate was used as a highly specific radiotracer for imaging of adrenocortical tissue [21] . Till now no publications are available in which this radiotracer was used in children. We believe therefore that the use of scintigraphy should be restricted to the rare cases in which the conventional diagnostic strategies failed. Prediagnostic treatment with dexamethasone is recommended in order to suppress the regular adrenal glands. Overall, our patient had concomitant intra-adrenal as well as ectopic adenomas of adrenal origin. Usually, hormone-secreting adenomas which are located bilaterally produce cortisol [22] , bilateral ACT secreting androgens are extremely rare [23] . Uncommonly, ectopic adrenal tissue can become clinically apparent. To our knowledge, only 2 cases of an ectopic cortical adrenal mass in the thorax and behind the iliopsoas muscle, producing strictly androgens, have been reported in adults [8, 9] . Louiset et al. [24] described an ACTHindependent Cushing´s syndrome with bilateral micronodular adrenal hyperplasia and ectopic adrenocortical adenoma. But the combination of ectopic and intra-adrenal adenoma-secreting androgens is not described until now. In our patient, both adenomas demonstrate common histological features. To verify that the ectopic tumor was of adrenal origin, we checked the expression of MC2R, which was readily detectable by realtime PCR. Interestingly, no suppression of androgens was observable after dexamethasone administration, despite the high expression of MC2R indicating autonomous activation of steroidogenesis. Because both tumors demonstrated the identical histological picture and androgens decreased half after the first operation we could speculate that both tumor parts contribute equally to the androgen secretion.
Ectopic adrenal tissue is estimated to occur in about 1% of the adult population and up to 50% in neonates. Usually, ectopic adrenal tissue regresses in early infancy [25] . The adrenal cortex develops from the coelomic mesoderm of the urogenital ridge during the 5th week of gestational age and separates from it during the 8th week [26, 27] . Ectopic adrenal tissue occurs when a fragment of the primitive adrenal gland sheds off during development. It may rest in any visceral organ, more frequently in the kidney, liver, and gonads. Ectopic adrenal tissue may contain both cortex and medulla, if the breaking event occurs after migration of neural crest tissue into the cortex.
Assessing the malignant potential of adrenal tumors solely on the basis of pathological examination can prove to be difficult. Tumor weight and size, signs of vascular invasion and a high mitotic index are morphological signs of tumor carcinogenic potential. A tumor weight more than 100 g and a diameter greater than 5 cm are indicators of malignancy and infiltration of the surrounding tissue or presence of metastases are obvious signs for carcinoma [17, 28, 29] . In uncertain cases, even established histopathological criteria and algorithms adapted from tumors in adults generally do not allow clear classification in children [29] [30] [31] .
Recently, molecular and genetic markers have been assessed for their potential to differentiate adrenocortical carcinomas from benign adenomas [30] [31] [32] [33] [34] [35] [36] [37] . In our patient, analysis of steroid hormones revealed only hyperandrogenism. Generally, adrenal cortical carcinomas presents more commonly as a mixed Cushing-virilizing syndrome [38] . Histology investigation of both adenomas demonstrated Ki67 proliferation index of 2-5% and no invasion of the capsula or vessels were detected. The analysis of the steroid hormones and the histological evaluation led us assume, that in our case the tumor has no malignant potential, but prolonged and vigilant follow up is absolutely necessary.
The treatment of choice for adrenal lesions with autonomous steroid secretion or signs indicative of malignancy is radical resection of the complete tumor by open abdominal or laparoscopic surgery. Long-term follow-up is advisable for detecting recurrence of the disease.
Our findings underline that androgen-producing adenomas may be located within and/or outside the adrenal cortex, and may provoke severe virilization in prepubertal girls. MC2 receptor expression in the tumor indicates the adrenal cortex's descent. Specific functional imaging, if available, can assist in allocating the source of androgen hypersecretion. Long-term follow-up is warranted to assure complete removal of the adenomas.
